RGS17 anticorps (AA 148-160)
Aperçu rapide pour RGS17 anticorps (AA 148-160) (ABIN1886054)
Antigène
Voir toutes RGS17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 148-160
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 148 and 160 (Q9UGC6) of RGS17
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 1 x PBS, 1 % BSA, 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- RGS17 (Regulator of G-Protein Signaling 17 (RGS17))
-
Autre désignation
- RGS17
-
Sujet
-
This gene encodes a member of the regulator of G-protein signaling family.This protein contains a conserved, 120 amino acid motif called the RGS domain and a cysteine-rich region.The protein attenuates the signaling activity of G-proteins by binding to activated, GTP-bound G alpha subunits and acting as a GTPase activating protein (GAP), increasing the rate of conversion of the GTP to GDP.This hydrolysis allows the G alpha subunits to bind G beta/gamma subunit heterodimers, forming inactive G-protein heterotrimers, thereby terminating the signal.[provided by RefSeq]
-
Poids moléculaire
- 24 kDa
-
ID gène
- 26575
-
NCBI Accession
- NM_012419, NP_036551
-
Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-